期刊
FEBS LETTERS
卷 583, 期 18, 页码 3021-3026出版社
WILEY
DOI: 10.1016/j.febslet.2009.08.009
关键词
Amyloid precursor protein secretases; Amyloid beta protein; Bace1 protein, mouse; Immunohistochemistry; Intracellular space; Mice, transgenic
资金
- Uppsala University
- Land-stinge t i Uppsala lan
- The Swedish Brain Fund
- Bertil Hallstens Forskningsstiftelse
- Alzheimerfonden
- Demensfonden
- Gamla Tjnarinnor
- Gun och Bertil Stohnes Stiftelse
- Magnus Bergvall
- Ahlnsstiftelsen
- Lars Hierta
- Lundstroms Minne
- Frimurarstiftelsen
- Svenska Lakarsallskapet
- Swedish Research Council [2006-2822, 2006-2818]
Intraneuronal punctate immunostaining in Alzheimer's disease brain and amyloid-beta precursor protein (APP) transgenic mice has been suggested to represent A beta, but this is somewhat controversial. Here we show that both biochemical A beta levels and intraneuronal immunostaining are reduced in APP transgenic mice when gamma-secretase is inhibited. Moreover, BACE-1 deficient APP transgenic mice show neither A beta production nor intraneuronal immunostaining. Our findings suggest that the punctate immunostaining with APP antibodies is due to A beta that has accumulated inside neurons. Similar type of intraneuronal A beta accumulation, which precedes senile plaque formation, may link A beta to tauopathy and neurodegeneration in Alzheimer's disease pathogenesis. (C) 2009 Federation of European Biochemical Societies. Published by Elsevier B. V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据